DE60023873D1 - Mittel zur behandlung von erkrankungen der speiseröhre - Google Patents

Mittel zur behandlung von erkrankungen der speiseröhre

Info

Publication number
DE60023873D1
DE60023873D1 DE60023873T DE60023873T DE60023873D1 DE 60023873 D1 DE60023873 D1 DE 60023873D1 DE 60023873 T DE60023873 T DE 60023873T DE 60023873 T DE60023873 T DE 60023873T DE 60023873 D1 DE60023873 D1 DE 60023873D1
Authority
DE
Germany
Prior art keywords
dishes
medicine
treating disorders
disorders
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60023873T
Other languages
English (en)
Other versions
DE60023873T2 (de
Inventor
Peter William Dettmar
Paul Andrew Dickson
Frank Chadwick Hampson
Ian Gordon Jolliffe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt Benckiser Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare UK Ltd filed Critical Reckitt Benckiser Healthcare UK Ltd
Publication of DE60023873D1 publication Critical patent/DE60023873D1/de
Application granted granted Critical
Publication of DE60023873T2 publication Critical patent/DE60023873T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60023873T 1999-05-05 2000-05-04 Mittel zur behandlung von erkrankungen der speiseröhre Expired - Lifetime DE60023873T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9910212 1999-05-05
GBGB9910212.1A GB9910212D0 (en) 1999-05-05 1999-05-05 Improvements in or relating to organic compositions
PCT/GB2000/001711 WO2000067799A1 (en) 1999-05-05 2000-05-04 Compositions for treatment of disorders of the oesophagus

Publications (2)

Publication Number Publication Date
DE60023873D1 true DE60023873D1 (de) 2005-12-15
DE60023873T2 DE60023873T2 (de) 2006-08-03

Family

ID=10852720

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60023873T Expired - Lifetime DE60023873T2 (de) 1999-05-05 2000-05-04 Mittel zur behandlung von erkrankungen der speiseröhre
DE69940131T Expired - Lifetime DE69940131D1 (de) 1999-05-05 2000-05-04 Mittel zur Behandlung von Erkrankungen der Speiseröhre

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69940131T Expired - Lifetime DE69940131D1 (de) 1999-05-05 2000-05-04 Mittel zur Behandlung von Erkrankungen der Speiseröhre

Country Status (15)

Country Link
US (1) US6610667B1 (de)
EP (2) EP1614431B1 (de)
JP (1) JP2002544176A (de)
CN (1) CN1173743C (de)
AR (1) AR023876A1 (de)
AT (2) ATE417602T1 (de)
AU (1) AU774966B2 (de)
BR (1) BR0010209A (de)
CA (1) CA2371031C (de)
DE (2) DE60023873T2 (de)
ES (1) ES2251997T3 (de)
GB (2) GB9910212D0 (de)
PL (1) PL199445B1 (de)
WO (1) WO2000067799A1 (de)
ZA (1) ZA200109073B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2368013B (en) * 2001-02-19 2004-07-28 Richard Orlando Brown An antacid composition which comprise multiple pharmacologically active ingredients for the symptomatic management of pain
GB2398496A (en) * 2003-02-20 2004-08-25 Reckitt Benckiser Healthcare Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles
US20040185119A1 (en) * 2003-02-26 2004-09-23 Theuer Richard C. Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency
ITRM20030154A1 (it) * 2003-04-03 2004-10-04 D M G Italia S R L Sciroppo antireflusso.
KR101179541B1 (ko) * 2003-04-25 2012-09-05 레킷트 벵키저 헬스케어(유케이)리미티드 증점성 조성물
US7297786B2 (en) 2004-07-09 2007-11-20 University Of Iowa Research Foundation RNA interference in respiratory epitheial cells
FR2876581B1 (fr) * 2004-10-20 2007-05-18 Interpharm Dev Composition bioadhesive a liberation programmee
JP4775807B2 (ja) * 2004-12-02 2011-09-21 株式会社 メドレックス 局所麻酔薬物含有ゼリー剤
US8062686B2 (en) * 2005-04-12 2011-11-22 InovoBiologics, Inc. Dietary supplement, and methods of use
US8597709B2 (en) * 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use
PL1931222T3 (pl) * 2005-10-05 2012-07-31 Technostics Ltd Żelujące kompozycje i sposoby
EP1859786A1 (de) * 2006-05-16 2007-11-28 Frutarom Netherlands B.V. Methode zu vermindern die Symptome von Sodbrennen und Gastro-speiseröhren Rücklaufkrankheit durch spezifischen polysaccharides
BRPI0704542B8 (pt) * 2007-05-15 2021-05-25 Univ Estadual Campinas Unicamp composição farmacêutica, processo de obtenção da composição farmacêutica, uso de uma quantidade farmaceuticamente eficaz de anestésico e agente gelificante, produto e método de tratamento
AU2014262248B2 (en) * 2007-07-30 2017-05-04 Inovobiologic, Inc. Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
US8143314B1 (en) 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
EP3354276B1 (de) * 2007-11-13 2020-01-01 Meritage Pharma, Inc. Zusammensetzungen zur behandlung von magen-darm-entzündung
US20090145433A1 (en) * 2007-12-08 2009-06-11 Michael James Apparatus for dispensing a powdered composition into the aerodigestive tract
US20090148530A1 (en) * 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
WO2009089134A1 (en) * 2008-01-04 2009-07-16 Src, Inc. Methods for measuring a patint response upon administration of a drug and compositions thereof
AU2009212328B2 (en) * 2008-02-08 2011-12-08 Colgate-Palmolive Company Effervescent compositions
EA018333B1 (ru) 2008-05-13 2013-07-30 Афарм С.Р.Л. Применение гликозаминогликанов для перорального введения и композиции гликозаминогликанов
JP2011520869A (ja) * 2008-05-15 2011-07-21 フイルメニツヒ ソシエテ アノニム 活性成分のためのデリバリーシステム
WO2010108494A1 (en) * 2009-03-25 2010-09-30 S-Biotek Holding Aps Dayspepsia treatment with alginate
ES2428337T3 (es) 2009-05-25 2013-11-07 Sofar Swiss Sa Uso de una combinación fija de glucosaminoglucanos y composición masticable que comprende dicha combinación fija
TR201005241A1 (tr) * 2010-05-25 2012-01-23 Sanovel �La� San. Ve T�C. A.�. Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
ITRM20120041A1 (it) 2012-02-08 2013-08-09 Dicofarm Spa "prodotto a base di glucomannano e chitosano utile per il trattamento del reflusso gastroesofageo"
US9452135B2 (en) 2012-03-20 2016-09-27 Particle Dynamics International, Llc Gelling agent-based dosage form
US9636360B2 (en) 2012-09-18 2017-05-02 pH Science Holdings, Inc Method and composition for treating gastro-esophageal disorders
IT201600088648A1 (it) * 2016-08-31 2018-03-03 Alpiflor S R L Composizione nutrizionale o farmaceutica ed integratore alimentare contenente detta compsizione nutrizionale o farmaceutica
IT201600121617A1 (it) * 2016-11-30 2018-05-30 Nekkar Lab Srl Composizione per il trattamento del reflusso gastroesofageo
IT201600121601A1 (it) * 2016-11-30 2018-05-30 Nekkar Lab Srl Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo
CN106420773A (zh) * 2016-12-21 2017-02-22 郑州莉迪亚医药科技有限公司 一种治疗放射性肠炎的中西药组合物及其制备方法和应用
IT201700108526A1 (it) 2017-09-28 2019-03-28 Alfasigma Spa Composizioni orali per il trattamento del refluso gastroesofageo.
WO2019172261A1 (ja) * 2018-03-05 2019-09-12 国立大学法人東京大学 食道狭窄防止材料
CN109432232B (zh) * 2018-12-07 2021-11-26 纽湃腾（北京）医药科技有限公司 一种改善调节胃食管反流的海藻酸盐组合物及应用
CN109432233A (zh) * 2018-12-07 2019-03-08 纽湃腾（北京）医药科技有限公司 一种含有猴头菇提取物的抑反流护胃组合物及应用
CN110840853A (zh) * 2019-10-26 2020-02-28 张强 胃镜检查用咀嚼或含化型口咽部局麻药及服用方法
US11324727B2 (en) 2020-07-15 2022-05-10 Schabar Research Associates, Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
CN116194102A (zh) 2020-07-15 2023-05-30 沙巴研究联合有限责任公司 用于治疗急性疼痛和降低胃灼热的严重程度和/或风险的包含布洛芬和法莫替丁的单位口服剂量组合物
IT202000031433A1 (it) * 2020-12-18 2022-06-18 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizioni comprendenti saccarosio octasolfato per il trattamento del reflusso gastrico
IT202000031421A1 (it) * 2020-12-18 2022-06-18 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione multicomponente comprendente saccarosio solfato o suoi derivati per il trattamento del reflusso gastrico
IT202000031409A1 (it) * 2020-12-18 2022-06-18 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione multicomponente comprendente gomma gellano e suo uso per il trattamento del reflusso gastrico
EP4262823A1 (de) * 2020-12-18 2023-10-25 Drugs Minerals and Generics Italia S.R.L. In Forma Abbreviata D.M.G. Italia S.R.L. Mehrkomponentige zusammensetzung mit einem gellangummi und verwendung davon zur behandlung von magenreflux

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57133170A (en) * 1981-02-12 1982-08-17 Kikusui Kagaku Kogyo Kk Thermochromic coating compound with colorful pattern
US4717713A (en) 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
GB8911177D0 (en) * 1989-05-16 1989-07-05 Vilain Jean Alginate gel pharmaceutical product
DE69231281T2 (de) * 1991-12-17 2001-03-01 Biovail Technologies Ltd.(N.D.Ges.D.Staates Delaware), Chantilly Zusammensetzung und verfahren zur ulcusprävention und -behandlung
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
GB9708773D0 (en) 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
US6030641A (en) * 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same

Also Published As

Publication number Publication date
CN1173743C (zh) 2004-11-03
EP1173218A1 (de) 2002-01-23
GB0010669D0 (en) 2000-06-28
AU4590000A (en) 2000-11-21
EP1614431A2 (de) 2006-01-11
EP1173218B1 (de) 2005-11-09
EP1614431B1 (de) 2008-12-17
ATE417602T1 (de) 2009-01-15
BR0010209A (pt) 2002-02-19
AR023876A1 (es) 2002-09-04
CN1349418A (zh) 2002-05-15
ZA200109073B (en) 2003-01-29
GB9910212D0 (en) 1999-06-30
GB2349570A (en) 2000-11-08
DE69940131D1 (de) 2009-01-29
CA2371031C (en) 2008-09-30
JP2002544176A (ja) 2002-12-24
US6610667B1 (en) 2003-08-26
WO2000067799A1 (en) 2000-11-16
EP1614431A3 (de) 2006-03-01
PL351134A1 (en) 2003-03-24
PL199445B1 (pl) 2008-09-30
GB2349570B (en) 2002-05-22
ES2251997T3 (es) 2006-05-16
ATE308997T1 (de) 2005-11-15
CA2371031A1 (en) 2000-11-16
AU774966B2 (en) 2004-07-15
DE60023873T2 (de) 2006-08-03

Similar Documents

Publication Publication Date Title
DE60023873D1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE69922914D1 (de) Stimulationssystem zur Behandlung von Erkrankungen bezüglich des Magenspeiseröhrenreflux
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE376994T1 (de) Adamantanderivate zur behandlung von entzündlichen, immunologischen und kardiovaskulären erkrankungen
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
DE60022916D1 (de) Reboxetin zur Behandlung von peripheren Neuropathien
DE60031710D1 (de) Fettsäurederivat zur behandlung von externen sekretionsstörungen
ATE292134T1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE295174T1 (de) Arzneimittel zur behandlung von bluthochdruck
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE69838785D1 (de) Pharmazeutische mittel zur behandlung von zerebralen amyloidosis
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
ATE314064T1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
DE60036723D1 (de) Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen
ATE251167T1 (de) Oxazinocarbazole zur behandlung von cns- erkrankungen
DE60017174D1 (de) Rivastigmine zur behandlung von augenerkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition